- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Sabin Inactivated Polio vaccine (sIPV) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Sabin Inactivated Polio vaccine (sIPV) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Sabin Inactivated Polio vaccine (sIPV) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sabin Inactivated Polio vaccine (sIPV) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sabin Inactivated Polio vaccine (sIPV) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sabin Inactivated Polio vaccine (sIPV) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sabin Inactivated Polio vaccine (sIPV)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sabin Inactivated Polio vaccine (sIPV) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biokangtai, Sinovac, Imbcams, Intravacc and Beijing Biological. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Sabin Inactivated Polio vaccine (sIPV) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vials
Syringes
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Biokangtai
Sinovac
Imbcams
Intravacc
Beijing Biological
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sabin Inactivated Polio vaccine (sIPV) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sabin Inactivated Polio vaccine (sIPV), with price, sales, revenue and global market share of Sabin Inactivated Polio vaccine (sIPV) from 2018 to 2023.
Chapter 3, the Sabin Inactivated Polio vaccine (sIPV) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sabin Inactivated Polio vaccine (sIPV) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sabin Inactivated Polio vaccine (sIPV) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sabin Inactivated Polio vaccine (sIPV).
Chapter 14 and 15, to describe Sabin Inactivated Polio vaccine (sIPV) sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Sabin Inactivated Polio vaccine (sIPV)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vials
1.3.3 Syringes
1.4 Market Analysis by Application
1.4.1 Overview: Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Sabin Inactivated Polio vaccine (sIPV) Market Size & Forecast
1.5.1 Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (2018-2029)
1.5.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Biokangtai
2.1.1 Biokangtai Details
2.1.2 Biokangtai Major Business
2.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product and Services
2.1.4 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biokangtai Recent Developments/Updates
2.2 Sinovac
2.2.1 Sinovac Details
2.2.2 Sinovac Major Business
2.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product and Services
2.2.4 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sinovac Recent Developments/Updates
2.3 Imbcams
2.3.1 Imbcams Details
2.3.2 Imbcams Major Business
2.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Product and Services
2.3.4 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Imbcams Recent Developments/Updates
2.4 Intravacc
2.4.1 Intravacc Details
2.4.2 Intravacc Major Business
2.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Product and Services
2.4.4 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intravacc Recent Developments/Updates
2.5 Beijing Biological
2.5.1 Beijing Biological Details
2.5.2 Beijing Biological Major Business
2.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product and Services
2.5.4 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Biological Recent Developments/Updates
3 Competitive Environment: Sabin Inactivated Polio vaccine (sIPV) by Manufacturer
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Manufacturer (2018-2023)
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Sabin Inactivated Polio vaccine (sIPV) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Sabin Inactivated Polio vaccine (sIPV) Manufacturer Market Share in 2022
3.4.2 Top 6 Sabin Inactivated Polio vaccine (sIPV) Manufacturer Market Share in 2022
3.5 Sabin Inactivated Polio vaccine (sIPV) Market: Overall Company Footprint Analysis
3.5.1 Sabin Inactivated Polio vaccine (sIPV) Market: Region Footprint
3.5.2 Sabin Inactivated Polio vaccine (sIPV) Market: Company Product Type Footprint
3.5.3 Sabin Inactivated Polio vaccine (sIPV) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2018-2029)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2018-2029)
4.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Region (2018-2029)
4.2 North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029)
4.3 Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029)
4.4 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029)
4.5 South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029)
4.6 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
5.2 Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type (2018-2029)
5.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
6.2 Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application (2018-2029)
6.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Application (2018-2029)
7 North America
7.1 North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
7.2 North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
7.3 North America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country
7.3.1 North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2029)
7.3.2 North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
8.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
8.3 Europe Sabin Inactivated Polio vaccine (sIPV) Market Size by Country
8.3.1 Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2029)
8.3.2 Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Market Size by Region
9.3.1 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
10.2 South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
10.3 South America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country
10.3.1 South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2029)
10.3.2 South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Market Size by Country
11.3.1 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Sabin Inactivated Polio vaccine (sIPV) Market Drivers
12.2 Sabin Inactivated Polio vaccine (sIPV) Market Restraints
12.3 Sabin Inactivated Polio vaccine (sIPV) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Sabin Inactivated Polio vaccine (sIPV) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sabin Inactivated Polio vaccine (sIPV)
13.3 Sabin Inactivated Polio vaccine (sIPV) Production Process
13.4 Sabin Inactivated Polio vaccine (sIPV) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sabin Inactivated Polio vaccine (sIPV) Typical Distributors
14.3 Sabin Inactivated Polio vaccine (sIPV) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 4. Biokangtai Major Business
Table 5. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product and Services
Table 6. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Biokangtai Recent Developments/Updates
Table 8. Sinovac Basic Information, Manufacturing Base and Competitors
Table 9. Sinovac Major Business
Table 10. Sinovac Sabin Inactivated Polio vaccine (sIPV) Product and Services
Table 11. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sinovac Recent Developments/Updates
Table 13. Imbcams Basic Information, Manufacturing Base and Competitors
Table 14. Imbcams Major Business
Table 15. Imbcams Sabin Inactivated Polio vaccine (sIPV) Product and Services
Table 16. Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Imbcams Recent Developments/Updates
Table 18. Intravacc Basic Information, Manufacturing Base and Competitors
Table 19. Intravacc Major Business
Table 20. Intravacc Sabin Inactivated Polio vaccine (sIPV) Product and Services
Table 21. Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Intravacc Recent Developments/Updates
Table 23. Beijing Biological Basic Information, Manufacturing Base and Competitors
Table 24. Beijing Biological Major Business
Table 25. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product and Services
Table 26. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing Biological Recent Developments/Updates
Table 28. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in Sabin Inactivated Polio vaccine (sIPV), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Sabin Inactivated Polio vaccine (sIPV) Production Site of Key Manufacturer
Table 33. Sabin Inactivated Polio vaccine (sIPV) Market: Company Product Type Footprint
Table 34. Sabin Inactivated Polio vaccine (sIPV) Market: Company Product Application Footprint
Table 35. Sabin Inactivated Polio vaccine (sIPV) New Market Entrants and Barriers to Market Entry
Table 36. Sabin Inactivated Polio vaccine (sIPV) Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Sabin Inactivated Polio vaccine (sIPV) Raw Material
Table 96. Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV) Raw Materials
Table 97. Sabin Inactivated Polio vaccine (sIPV) Typical Distributors
Table 98. Sabin Inactivated Polio vaccine (sIPV) Typical Customers
List of Figures
Figure 1. Sabin Inactivated Polio vaccine (sIPV) Picture
Figure 2. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Type in 2022
Figure 4. Vials Examples
Figure 5. Syringes Examples
Figure 6. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Sabin Inactivated Polio vaccine (sIPV) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Sabin Inactivated Polio vaccine (sIPV) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Sabin Inactivated Polio vaccine (sIPV) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Sabin Inactivated Polio vaccine (sIPV) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Sabin Inactivated Polio vaccine (sIPV) Market Drivers
Figure 74. Sabin Inactivated Polio vaccine (sIPV) Market Restraints
Figure 75. Sabin Inactivated Polio vaccine (sIPV) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Sabin Inactivated Polio vaccine (sIPV) in 2022
Figure 78. Manufacturing Process Analysis of Sabin Inactivated Polio vaccine (sIPV)
Figure 79. Sabin Inactivated Polio vaccine (sIPV) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
